Henry Gosebruch

Henry Gosebruch currently serves as President and CEO of Neumora since July 2023 and as a Board Member at ACELYRIN, INC. since March 2023. Prior to these roles, Henry held the position of EVP and Chief Strategy Officer at AbbVie from December 2015 to February 2023. Additionally, Henry co-led Mergers & Acquisitions for North America at J.P. Morgan from June 1995 until December 2015. Henry Gosebruch earned a BSE in Finance and Management from The Wharton School between 1992 and 1995.